Familial clustering of ALS in a population-based resource

Neurology

Volumn 82, Issue 1, 2014, Pages 17-22

  Gibson, Summer B ^a   Figueroa, Karla P ^a   Bromberg, Mark B ^a   Pulst, Stefan M ^a   Cannon Albright, Lisa ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; DEATH CERTIFICATE; DYING; FAMILY ASSESSMENT; FEMALE; FIRST DEGREE RELATIVE; HUMAN; ICD-10; MAJOR CLINICAL STUDY; MALE; MOLECULAR PHYLOGENY; PRIORITY JOURNAL; RISK ASSESSMENT; SECOND DEGREE RELATIVE;

EID: 84892145247     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000438219.39061.da     Document Type: Article

References (27)

1. Byrne S, Elamin M, Bede P, Hardiman O. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases. J Neurol Neurosurg Psychiatry 2012;83:365-367.
2. Byrne S, Walsh C, Lynch C, et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and metaanalysis. J Neurol Neurosurg Psychiatry 2011;82:623-627.
3. Chio A, Magnani C, Oddenino E, Tolardo G, Schiffer D. Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis. J Epidemiol Community Health 1992;46: 517-518.
4. Skolnick MH. The Utah genealogical database: a resource for genetic epidemiology. In: Cairns J, Lyon JH, Skolnick MH, editors. Banbury Report No. 4: Cancer Incidence in Defined Populations. New York: Cold Spring Harbor Laboratory; 1980:285-297.
5. McLellan T, Jorde LB, Skolnick MH. Genetic distances between the Utah Mormons and related populations. Am J Hum Genet 1984;36:836-857. (Pubitemid 14030098)
6. Jorde LB. Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet 1989;53:339-355. (Pubitemid 19282107)
7. Marin B, Couratier P, Preux PM, Logroscino G. Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 2011;36:29-38.
8. Hill JR. A survey of cancer sites by kinship in the Utah Mormon population. In: Cairns J, Lyon JH, Skolnick MH, editors. Banbury Report No. 4: Cancer Incidence in Defined Populations. New York: Cold Spring Harbor Laboratory; 1980:299-318.
9. Malécot G. Les Mathematiques de L'heredite. Paris: Masson & Cie; 1948.
10. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG. A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg 2003;99:637-643. (Pubitemid 37159039)
11. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008;197:18-24. (Pubitemid 351263461)
12. Teerlink CC, Camp NJ, Bansal A, et al. Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource. Eur J Hum Genet 2009;17:636-643.
13. McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med 2010;7:557-570.
14. Leone M. Parental sex effect in familial amyotrophic lateral sclerosis. Neurology 1991;41:1292-1294.
15. Leone M, De Angelis MS, Giordano M, Mutani R. Influence of ancestral gender on transmission of familial amyotrophic lateral sclerosis. Lancet 1994;344:1639. (Pubitemid 24365373)
16. Fang F, Kamel F, Lichtenstein P, et al. Familial aggregation of amyotrophic lateral sclerosis. Ann Neurol 2009;66: 94-99.
17. Hanby MF, Scott KM, Scotton W, et al. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain 2011;134:3454-3457.
18. Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012;11:323-330.
19. Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adultonset ALS and ALS/dementia. Nature 2011;477:211-215.
20. Kim HY, Ki CS, Koh SH, Park KH, Sunwoo IN, Kim SH. Clinical characteristics of familial amyotrophic lateral sclerosis with a Phe20Cys mutation in the SOD1 gene in a Korean family. Amyotroph Lateral Scler 2007;8: 73-78. (Pubitemid 46605390)
21. Aoki M, Abe K, Houi K, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn superoxide dismutase mutation. Ann Neurol 1995;37:676-679.
22. Murakami T, Warita H, Hayashi T, et al. A novel SOD1 gene mutation in familial ALS with low penetrance in females. J Neurol Sci 2001;189:45-47. (Pubitemid 32776648)
23. Wijchers PJ, Festenstein RJ. Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends Genet 2011;27:132-140.
24. Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci 2012;107:355-415.
25. Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:639-649.
26. Chio A, Magnani C, Schiffer D. Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology 1993;43:927-930. (Pubitemid 23150563)
27. Dean G, Quigley M, Goldacre M. Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 1994;57:450-454. (Pubitemid 24118140)